Actin	modulation of clot structure and properties (Talens et al. 2012)
Albumin	modulation of lateral aggregation and clot structure (Galanakis et al. 1987; Talens et al. 2012)
α1-Antitrypsin	local regulation of proteases involved in coagulation or fibrinolysis (Talens et al. 2012)
α2-Antiplasmin	local regulation of fibrinolysis (Tsurupa et al. 2010)
Apolipoproteins A-IV, A-I, J, E	associated with high-density lipoproteins; the physio logic role of binding to fibrin(ogen) is not clear (Talens et al. 2012)
Carboxypeptidase N	a local fibrinolysis inhibitor (Talens et al. 2012)
CD44	mediates tumor metastasis at the sites of fibrin deposition (Alves et al. 2009)
Coagulation Factor Xa	a negative feedback for thrombin generation (Iino et al. 1995)
Coagulation Factor VIII	platelet-attached soluble fibrin mediates binding of Factor VIII (Gilbert et al. 2015)
Coagulation Factor XIII	crosslinking of fibrin and multiple plasma proteins (Weisel and Dempfle 2013)
Complement C3	delayed fibrinolysis (Howes et al. 2012)
Factor H-related proteins-associated lipoprotein particles (FALP)	the physiologic role of fibrinogen on FALP is not clear (Park and Wright 2000)
Ferritin	some fibrinogens circulate in the form of a complex with ferritin (Takahashi et al. 2013)
Fibroblast Growth Factor-2	augmented angiogenesis and cell proliferation at the sites of fibrin deposition (Sahni et al. 1999)
Fibulin	interferes with the fibrin assembly (Tran et al. 1995)
Haptoglobin	associated with high-density lipoproteins; the physiologic role of binding to fibrin(ogen) is not clear (Talens et al. 2012)
Hepatocyte-derived fibrinogen related protein-1	liver cell growth regulation (Talens et al. 2012)
Immunoglobulins	modulate fibrin structure, localize immune and inflam matory reactions (Talens et al. 2012)
Interleukin-1β	modulation of inflammation (Sahni et al. 2004)
Lipoprotein(a)	modulation of fibrinolysis (Weisel and Litvinov 2014)
α2-Macroglobulin	local regulation of proteases involved in coagulation or fibrinolysis (Talens et al. 2012)
Myosin	modulation of fibrinolysis (Kolev et al. 2003)
Plasma fibronectin	platelet adhesion and thrombus formation (Gailit and Ruoslahti 1988; Talens et al. 2012)
Plasminogen	promotion of fibrinolysis (Weisel and Litvinov 2014)
Plasminogen activator inhibitor-1	modulation of fibrinolysis (Smolarczyk et al. 2005)
Serum amyloid P	associated with high-density lipoproteins; the physiologic role of binding to fibrin(ogen) is not clear (Talens et al. 2012)
Thrombin	elimination of active thrombin from the circulation (Weisel and Dempfle 2013)
Thrombin-activatable fibrinolysis inhibitor (TAFI)	modulation of fibrinolysis (Valnickova and Enghild 1998)
Thrombospondin	modulation of fibrinolysis (Bacon-Baguley et al. 1990)
Tissue-type plasminogen activator (t-PA)	promotion of fibrinolysis (Medved et al. 2001)
Vascular Endothelial Growth Factor (VEGF)	promotion of angiogenesis at the sites of fibrin deposition (Sahni and Francis 2000)
VE-cadherin	suppression of inflammation by inhibiting leukocyte transmigration at the sites of fibrin deposition (Yakovlev et al. 2011)
Very low density lipoprotein receptor (VLDLR)	promotion of inflammation and transendothelial migration of leukocytes at the sites of fibrin deposition (Yakovlev and Medved 2015)
Vitronectin	platelet adhesion and thrombus formation (Schvartz et al. 2002; Podor et al. 2002)
von Willebrand Factor	platelet adhesion and thrombus formation (Miszta et al. 2014)